Phenylpyazoleanilides as a Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 1: A New Class of Orally Available Immunomodulators

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|5|2|111-115

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.5, Iss.2, 2008-03, pp. : 111-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phenylpyazoleanilides as Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 2: Discovery of a New Drug Candidate, Y-320

By  

Letters in Drug Design & Discovery, Vol. 5, Iss. 4, 2008-06 ,pp. : 292-296

Bentham Science Publishers

Access to resources Recommend Favorite

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

By Sonpavde Guru   Hutson Thomas E   Sternberg Cora N  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 253-261

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of the peptidomimetic, MEN 11149, a new potent, selective and orally effective tachykinin NK 1 receptor antagonist

By Cirillo R.   Astolfi M.   Conte B.   Lopez G.   Parlani M.   Terracciano R.   Fincham C.I.   Manzini S.  

European Journal of Pharmacology, Vol. 341, Iss. 2, 1998-01 ,pp. : 201-209

Elsevier

Access to resources Recommend Favorite

New Fluoroquinolones: A Class of Potent Antibiotics

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-11 ,pp. : 1009-1017

Bentham Science Publishers

Access to resources Recommend Favorite

Triterpene esters from Uncaria rhynchophylla drive potent IL-12-dependent Th1 polarization

By Umeyama Akemi  

Journal of Natural Medicines, Vol. 64, Iss. 4, 2010-10 ,pp. : 506-509

Springer Publishing Company

Access to resources Recommend Favorite